Biolife Sciences (Biolife Sciences) Short-Term Debt : $2.44 Mil (As of May. 2008)

View and export this data going back to 2005. Start your Free Trial

What is Biolife Sciences Short-Term Debt?

Biolife Sciences's Short-Term Debt for the quarter that ended in May. 2008 was $2.44 Mil.

Biolife Sciences's quarterly Short-Term Debt declined from Nov. 2007 ($2.45 Mil) to Feb. 2008 ($2.33 Mil) but then increased from Feb. 2008 ($2.33 Mil) to May. 2008 ($2.44 Mil).

Biolife Sciences's annual Short-Term Debt increased from Nov. 2005 ($0.00 Mil) to Nov. 2006 ($2.34 Mil) and increased from Nov. 2006 ($2.34 Mil) to Nov. 2007 ($2.45 Mil).

Biolife Sciences Short-Term Debt Historical Data

The historical data trend for Biolife Sciences's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biolife Sciences Short-Term Debt Chart

Biolife Sciences Annual Data

Trend

Nov04

Nov05

Nov06

Nov07

Short-Term Debt

0.02

2.34

2.45

Biolife Sciences Quarterly Data
	Nov04	Feb05	May05	Aug05	Nov05	Feb06	May06	Aug06	Nov06	Feb07	May07	Aug07	Nov07	Feb08	May08
Short-Term Debt	Get a 7-Day Free Trial										0.16	2.10	2.45	2.33	2.44

Biolife Sciences Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Biolife Sciences Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Biolife Sciences's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Biolife Sciences (Biolife Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biolife Sciences Inc (OTCPK:BLFE) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

2831 Street Rose Parkway, No. 200, Henderson, NV, USA, 89052

Website

https://www.biolifesciences.com

Biolife Sciences Inc is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and beverage industry sectors. The company's technologies include antimicrobial copper air filters and copper-infused textiles. Its revenues are primarily generated from the sale of sanitation products.

Executives

Arthur Viola

director, 10 percent owner, officer: CEO

Biolife Sciences (Biolife Sciences) Headlines

From GuruFocus

Rhino Novi Announces Name Change and New CEO

By Marketwired Marketwired • 09-15-2020